|
| Status |
Public on Jul 01, 2011 |
| Title |
hsa-miR-191, a potential target for Hepatocellular carcinoma therapy |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
Non-coding RNA profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
20924108 |
| |
| Submission date |
Jul 13, 2010 |
| Last update date |
Jul 26, 2018 |
| Contact name |
Einat Sitbon |
| Organization name |
Rosetta Genomics
|
| Street address |
10 Plaut St
|
| City |
Rehovot |
| ZIP/Postal code |
76706 |
| Country |
Israel |
| |
|
| Platforms (3) |
| GPL6244 |
[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] |
| GPL10651 |
Rosetta Genomics human miRNA array v33 (condensed) |
| GPL10676 |
Rosetta Genomics human miRNA array v34 (condensed) |
|
| Samples (8)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE22790 |
Gene expression after treatment with anti-miR-191 or control |
| GSE22793 |
miR expression after treatment with anti-miR-191 or control |
| GSE22909 |
Influence of TCDD onto HCC cell line |
|
| Relations |
| BioProject |
PRJNA127965 |
Less...
More...